• Klaria Pharma will hold an extraordinary general meeting on Oct. 5, 2026, to vote on a rights issue of units.
• Each unit comprises four newly issued shares plus one TO1 warrant; subscription price set at SEK 2.4 per unit.
• The offering covers up to 61,494,038 units, raising about SEK 148 million before costs if fully subscribed.
• Shareholders will also vote to amend the articles to widen share-capital and share-count limits to support the issuance.
• A board authorization is proposed to issue units as potential guarantee compensation on the same terms as the rights issue.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Klaria Pharma Holding AB published the original content used to generate this news brief on September 01, 2026, and is solely responsible for the information contained therein.